Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Tulisokibart (MK-7240) in participants with moderately to severely active ulcerative colitis; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Tulisokibart

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Ulcerative Colitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING